SETDB1 enzyme deficiency was reported to be unable to inhibit the migration ability of lung cancer cells, indicating that the antitumour function of SETDB1 in lung cancer cells is dependent on its histone H3K9 methylase activity [115]. This evidence concerns the gene SETDB1 and lung carcinoma.